http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103751773-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-187 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 |
| filingDate | 2013-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103751773-B |
| titleOfInvention | The recombinant BHK cell system of stably express CSFV E0-E1-E2 albumen and in the application of preparing in hog cholera vaccine and diagnostic reagent |
| abstract | The invention discloses a kind of recombinant cell lines of stably express CSFV E0-E1-E2 albumen and in the application of preparing in hog cholera vaccine and diagnostic reagent. Wherein, the recombinant cell of described expression CSFV E0-E1-E2 albumen is BCSFV-E012, and this clone is deposited in China Committee for Culture Collection of Microorganisms's common micro-organisms center, does is its deposit number: CGMCC? No.7720. In addition, the invention also discloses the method for building up of stably express CSFV E0-E1-E2 albuminous cell system and use the method for the vaccine combination of described clone preparation prevention swine fever, further, the E0-E1-E2 albumen that the invention also discloses described recombinant cell lines expression is in the application of preparing in vaccine and the diagnostic reagent that prevents swine fever. The hog cholera vaccine that adopts recombinant cell lines of the present invention to prepare is safe, good immune effect, easily large-scale production, be not subject to exogenous virus pollution or antibody impact, and do not produce CSFV non-structural protein antibody, therefore can differentiate vaccine immunity and virus infections animal. |
| priorityDate | 2013-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 176.